Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines.

Jared Holz, Mizuho Securities America healthcare sector strategist, joins 'Squawk Box' to break down the quarterly earnings ...

Tanzania President, Namibia President Elect and Merck Foundation Chief Executive Officer (CEO) named amongst 100 Most ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... of expiring provisions in the 2017 Tax Cuts and Jobs Act might be slightly stimulative and positive for asset ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

The markets are likely to show some reactions to Donald Trump’s trade war, sparked by the US imposing sweeping tariffs on ...

A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...

After focusing on childhood vaccines during a 35-year career in the pharmaceutical industry ... Kimble spent more than three decades at Merck, last serving as director of global procurement ...

The Dow Jones is hitting a comfortable midrange around 44,450 on Tuesday. Threats of nearly-global tariffs have evaporated ...